22 May 2013
Keywords: intrinsa, gets, fda, priority, review, food, drug
Article | 27 September 2004
The US Food and Drug Administration has granted priority review to Procter & Gamble's Intrinsa, a testosterone skin patch for the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
27 September 2004
21 May 2013
© 2013 thepharmaletter.com